ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.

Matthew Mistry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.